Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 03, 2026
Oracle (ORCL): Can It Reclaim $300 After a -48% Drop?

Oracle (ORCL): Can It Reclaim $300 After a -48% Drop?

Key Takeaways

  • Oracle trades near $130 after plunging over 48% in the past year from its all-time high of $345.72, putting the $300 target roughly 130% above current levels.
  • The strongest bullish argument is Oracle's staggering $638 billion remaining performance obligations (RPO) backlog, representing nearly 10 times annual revenue and signaling extraordinary future demand for its cloud infrastructure.
  • Oracle Cloud Infrastructure (OCI) revenue continues accelerating, growing 84% to 93% year-over-year in recent quarters, driven by AI training workloads from customers including OpenAI, Meta, and NVIDIA.
  • The biggest obstacle is Oracle's ballooning debt load of approximately $167 billion and deeply negative free cash flow, as the company spends tens of billions annually building AI data centers before that revenue materializes.
  • Wall Street analysts remain broadly constructive, with consensus price targets around $248 to $261 and select firms such as TD Cowen and KeyBanc maintaining $300 targets, though several firms have cut estimates in 2026.
  • Reaching $300 would likely require sustained OCI growth above 80%, successful conversion of the RPO backlog into recognized revenue, and margin recovery as data center capacity reaches contractual utilization levels — a timeline that probably extends into 2027 or 2028.

Why Investors Are Watching for a $300 Recovery

Oracle Corporation (ORCL) reached an all-time high of $345.72 in September 2025, fueled by optimism around its role as a key AI infrastructure provider. Since then, the stock has fallen more than half its value amid worries over heavy capital spending, rising debt, and negative free cash flow. With shares now near $130 — down approximately 48% over the past twelve months — the possibility of a return to $300 stands out as one of the more closely watched questions in tech investing. The stock traded above $300 as recently as mid-2025, so this level serves as both a psychological and technical reference point.

Oracle's Current Market Position

Oracle's fiscal 2026 revenue reached $67.4 billion, up 17% year-over-year, while net income rose 37% to approximately $17 billion. The company trades at a price-to-earnings (P/E) ratio of roughly 22, well below its own five-year median P/E of about 32 and the broader technology sector average near 34. This valuation reflects investor caution around Oracle's capital structure more than doubts about revenue growth. The company ended fiscal 2026 with $638 billion in RPO — a 363% increase from the prior year — which offers strong visibility into future revenue. Approximately $77 billion of that backlog is expected to convert into recognized revenue during fiscal 2027 alone. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Bullish Drivers for a $300 Move

The case for Oracle reaching $300 centers on its fast-growing cloud infrastructure business. OCI revenue surged 84% to 93% year-over-year in recent quarters, supported by strong demand for AI training compute. Oracle's role in Project Stargate — the $500 billion AI infrastructure initiative alongside SoftBank, NVDA, and OpenAI — places it at the center of one of the largest technology buildouts in history. Oracle has also signed major cloud contracts with META and other large customers. Management guided for fiscal 2027 revenue of approximately $90 billion, a 34% increase, and analysts project fiscal 2028 revenue could reach $130 billion as OCI capacity comes online. Combined with expectations that infrastructure margins will improve once data centers reach full utilization, Oracle's EPS could surpass $10 by fiscal 2028. At a 30x P/E multiple — in line with Oracle's three-year historical average — that would support a stock price above $300.

Risks That Could Derail the Recovery

The challenges are significant and explain much of the current valuation. Oracle's debt load rose from approximately $85 billion to roughly $167 billion over the past year to fund data center construction. Free cash flow turned deeply negative at negative $23.7 billion in fiscal 2026. S&P downgraded Oracle's credit rating to BBB-, and credit default swap spreads widened. The company plans to raise an additional $40 billion through debt and equity in fiscal 2027, including a $20 billion share sale that will dilute existing shareholders. Oracle also cut approximately 21,000 jobs — about 13% of its workforce — during fiscal 2026 as part of an AI-driven restructuring. Gross margins are expected to face near-term pressure as new data centers ramp up before reaching full utilization. If AI infrastructure demand slows or hyperscale customers reduce GPU prepayments, the RPO conversion story could weaken.

What Analysts Are Saying

Wall Street remains cautiously optimistic overall. Of approximately 44 analysts covering Oracle, the majority rate the stock a Buy or Strong Buy, with an average 12-month price target near $248 to $261 — implying roughly 90% to 100% upside from current levels. The range is wide: the most cautious targets sit around $155 to $160, while Guggenheim maintains a high target of $400. TD Cowen, KeyBanc, and several other firms hold at $300. However, multiple firms — including Baird, Piper Sandler, and BMO Capital — have lowered their targets during 2026 amid concerns about financing needs and the timeline for margin recovery.

Key Technical Levels to Watch

From a technical standpoint, Oracle trades well below all major moving averages, approximately 21% beneath its 50-day moving average and roughly 28% under its 200-day moving average. The 52-week low of $114.50 represents important support — a break below that level would indicate further weakness. On the upside, the $200 level marks the first significant resistance zone, aligning with several revised analyst targets. Beyond $200, the $250 zone — near consensus — forms the next hurdle, with $300 serving as both a psychological round number and the key recovery target. The stock's beta of 1.71 highlights its sensitivity to shifts in market sentiment around AI spending.

Final Assessment

The question of whether Oracle can reach $300 again is not about demand — the $638 billion RPO backlog confirms that clearly. The real issues are whether Oracle can finance its infrastructure buildout without damaging its balance sheet and convert booked contracts into recognized revenue and free cash flow before credit markets grow impatient. The path to $300 likely requires sustained OCI growth above 80% through at least fiscal 2027 and visible margin improvement as data centers reach full utilization. Neither is guaranteed, but both are supported by contract data and management guidance. Investors should monitor quarterly OCI revenue growth rates, RPO conversion trends, gross margin trajectory, and any changes to Oracle's financing plans. A return to $300 probably extends into late 2027 or 2028, depending on execution that bridges the gap between the company's demand pipeline and its capital requirements.

AI Daily Buy/Sell Signals

To navigate volatile situations like this one, I often turn to Tickeron’s AI Daily Buy/Sell Signals. The tool uses artificial intelligence to monitor thousands of stocks and generate Buy, Sell, or Hold signals based on technical patterns and market conditions, helping separate real trend shifts from short-term noise when following a multi-year recovery story like Oracle’s.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ORCL

ORCL's RSI Indicator ascending out of oversold territory

The RSI Indicator for ORCL moved out of oversold territory on July 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 29 similar instances when the indicator left oversold territory. In of the 29 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on ORCL as a result. In of 70 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ORCL just turned positive on July 22, 2026. Looking at past instances where ORCL's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ORCL advanced for three days, in of 337 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORCL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ORCL broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ORCL entered a downward trend on August 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.751) is normal, around the industry mean (24.057). P/E Ratio (26.292) is within average values for comparable stocks, (74.273). Projected Growth (PEG Ratio) (0.866) is also within normal values, averaging (1.911). Dividend Yield (0.013) settles around the average of (0.021) among similar stocks. P/S Ratio (6.631) is also within normal values, averaging (134.061).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ORCL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), NetApp (NASDAQ:NTAP), Twilio (NYSE:TWLO), MongoDB (NASDAQ:MDB), Zscaler (NASDAQ:ZS), Okta (NASDAQ:OKTA).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 35.26B. The market cap for tickers in the group ranges from 48.8K to 3.66T. MSFT holds the highest valuation in this group at 3.66T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was 2%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 25%. AIFA experienced the highest price growth at 65%, while GYGY experienced the biggest fall at -33%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -28%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -65%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 72
Price Growth Rating: 56
SMR Rating: 80
Profit Risk Rating: 91
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
ORCL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of a diversified line of business software products

Industry ComputerCommunications

Profile
Details
Industry
Packaged Software
Address
2300 Oracle Way
Phone
+1 737 867-1000
Employees
164000
Web
https://www.oracle.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.